Content about MOUNTAIN VIEW

January 21, 2014

Vivus and Auxilium Pharmaceuticals announced that the Food and Drug Administration has accepted a supplemental application that proposes to revise the Stendra (avanafil) prescribing information with efficacy and safety information from Study TA-501, entitled "A Randomized, Double-Blind, Placebo-Controlled Evaluation of Avanafil for On-Demand Treatment of Men with Erectile Dysfunction."

MOUNTAIN VIEW, Calif. — Vivus and Auxilium Pharmaceuticals on Tuesday announced that the Food and Drug Administration has accepted a supplemental application that proposes to revise the Stendra (avanafil) prescribing information with efficacy and safety information from Study TA-501, entitled "A Randomized, Double-Blind, Placebo-Controlled Evaluation of Avanafil for On-Demand Treatment of Men with Erectile Dysfunction." 

The PDUFA date for the supplemental filing is Sept. 20, 2014.

January 17, 2014

Google is testing a smart contact lens that’s built to measure glucose levels in tears using a tiny wireless chip and miniaturized glucose sensor that are embedded between two layers of soft contact lens material, according to a blog outlining the project posted Thursday.

MOUNTAIN VIEW, Calif. — Google is testing a smart contact lens that’s built to measure glucose levels in tears using a tiny wireless chip and miniaturized glucose sensor that are embedded between two layers of soft contact lens material, according to a blog outlining the project posted Thursday. 

October 24, 2013

Coupons.com on Thursday announced the appointment of former Safeway executive Mir Aamir as the company’s CFO and COO. He will oversee all financial and accounting functions.

MOUNTAIN VIEW, Calif. — Coupons.com on Thursday announced the appointment of former Safeway executive Mir Aamir as the company’s CFO and COO. He will oversee all financial and accounting functions.  

The roles are presently managed by Richard Hornstein, the company’s CFO and general counsel. Hornstein will continue in the role of general counsel and chief legal officer, a role he has held for the past two-and-a-half years. Aamir, in addition to the finance functions, will also oversee the company’s operations and the international business.

October 16, 2013

CVS Caremark has announced that the first MinuteClinic locations in Northern California and the Bay Area have now opened inside select CVS/pharmacy stores in Santa Clara and San Mateo counties.

WOONSOCKET, R.I. — CVS Caremark has announced that the first MinuteClinic locations in Northern California and the Bay Area have now opened inside select CVS/pharmacy stores in Santa Clara and San Mateo counties.  

Three MinuteClinic locations are now operating in Foster City, San Jose and Sunnyvale CVS/pharmacy stores. Four additional clinics will begin to treat patients in November in Burlingame, Campbell, Mountain View and Santa Clara.

October 16, 2013

Patients taking a drug used for weight loss were able to reduce their chances of developing Type 2 diabetes, according to a new study.

MOUNTAIN VIEW, Calif. — Patients taking a drug used for weight loss were able to reduce their chances of developing Type 2 diabetes, according to a new study.

According to data from a 475-patient study published in the journal Diabetes Care, Vivus' Qsymia (phentermine and topiramate) reduced the annualized incidence rate of Type 2 diabetes by up to 78.7% in high-risk, overweight or obese patients with prediabetes or metabolic syndrome. Prediabetes is a condition in which a person has elevated blood sugar and a high risk of developing Type 2 diabetes.

October 14, 2013

More than three-quarters of Medicare beneficiaries don't compare drug prices when shopping for their health plans, according to a new study.

MOUNTAIN VIEW, Calif. — More than three-quarters of Medicare beneficiaries don't compare drug prices when shopping for their health plans, according to a new study.

The study, conducted by eHealth, found that 78% of respondents don't compare prices, but that the average beneficiary could have saved more than $600 this year on out-of-pocket prescription drug costs if he had. The study was based on an analysis of more than 450,000 unique visitor sessions during Medicare's 2013 Annual Enrollment Period.

September 17, 2013

Speck, a designer of slim-fitting protective cases and covers for smartphones, tablets and laptops, on Tuesday announced a new iPhone case for the iPhone 5 and 5s.

MOUNTAIN VIEW, Calif. — Speck, a designer of slim-fitting protective cases and covers for smartphones, tablets and laptops, on Tuesday announced a new iPhone case for the iPhone 5 and 5s.

August 20, 2013

A global population of patients with prediabetes that is three times the size of those who already have Type 2 diabetes has led to intense competition between drug makers to launch drugs to treat the disease, according to a new report.

MOUNTAIN VIEW, Calif. — A global population of patients with prediabetes that is three times the size of those who already have Type 2 diabetes has led to intense competition between drug makers to launch drugs to treat the disease, according to a new report.

July 1, 2013

A drug for treating obesity has become available through a network of about 8,000 retail pharmacies around the country, the drug's manufacturer said.

MOUNTAIN VIEW, Calif. — A drug for treating obesity has become available through a network of about 8,000 retail pharmacies around the country, the drug's manufacturer said Monday.

Vivus said the drug, Qsymia (phentermine; topiramate) extended-release capsules would be available at Costco and Walgreens stores, including Duane Reade stores. The launch is happening ahead of the previously announced mid-July launch date.

May 21, 2013

iHealth Lab Inc., today announced the release of two new fitness products to its existing lineup of wireless blood-pressure monitors and scales: the Wireless Pulse Oximeter and the Wireless Activity and Sleep Tracker. The company also announced new partnerships with two health and fitness communities, MyFitnessPal and RunKeeper.

MOUNTAIN VIEW, Calif. — iHealth Lab Inc., today announced the release of two new fitness products to its existing lineup of wireless blood-pressure monitors and scales: the Wireless Pulse Oximeter and the Wireless Activity and Sleep Tracker. The company also announced new partnerships with two health and fitness communities, MyFitnessPal and RunKeeper.

May 1, 2013

Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

LEVERKUSEN, Germany — Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

Bayer said its $31-per-share purchase of the Mountain View, Calif.-based company would allow it to expand its selection of contraception products. Conceptus makes Essure, a non-surgical permanent birth-control method, and Bayer said it would allow the company to offer a complete range of short-term, long-term and permanent contraceptive methods for women.

April 17, 2013

The Food and Drug Administration has approved a modification to a program added to the labeling of an obesity drug to ensure patient safety.

MOUNTAIN VIEW, Calif. — The Food and Drug Administration has approved a modification to a program added to the labeling of an obesity drug to ensure patient safety.

Vivus announced that the FDA had approved changes to the risk evaluation and mitigatin strategy for Qsymia (phentermine and topiramate) extended-release capsules. The amendment to the REMS allows the drug to be dispensed through certified retail pharmacies in addition to the existing network of mail-order pharmacies.

March 22, 2013

Culturally competent coaching may be effective in reducing the risk of coronary artery disease among South Asian patients, according to a new study presented as a poster at an American Heart Association conference taking place in New Orleans.

MOUNTAIN VIEW, Calif. — Culturally competent coaching may be effective in reducing the risk of coronary artery disease among South Asian patients, according to a new study presented as a poster at an American Heart Association conference taking place in New Orleans.

February 5, 2013

Budweiser's "Clydesdale" ad during the Super Bowl was the most effective aired during the football game, according to a new study.

MOUNTAIN VIEW, Calif. — Budweiser's "Clydesdale" ad during the Super Bowl was the most effective aired during the football game, according to a new study.

February 1, 2013

Patients who take a drug for losing weight may experience improvement in multiple cardiovascular disease risk factors, according to a new study.

MOUNTAIN VIEW, Calif. — Patients who take a drug for losing weight may experience improvement in multiple cardiovascular disease risk factors, according to a new study.

November 6, 2012

iHealth Labs on Tuesday announced that its latest suite of products will be available for purchase at major retailers and online later this month. The iHealth wireless blood pressure wrist monitor, wireless blood pressure monitor and wireless body analysis scale are already available at Best Buy and iHealthlabs.com, the company added.

MOUNTAIN VIEW, Calif. — iHealth Labs on Tuesday announced that its latest suite of products will be available for purchase at major retailers and online later this month. The iHealth wireless blood pressure wrist monitor, wireless blood pressure monitor and wireless body analysis scale are already available at Best Buy and iHealthlabs.com, the company added. 

September 19, 2012

Drug maker Vivus has released what it called the first new drug in 13 years for chronic weight management in adults.

MOUNTAIN VIEW, Calif. — Drug maker Vivus has released what it called the first new drug in 13 years for chronic weight management in adults.

The company announced the availability of Qsymia (phentermine and topiramate) extended-release capsules, which it is formally introducing to medical professionals this week at the Obesity Society's annual scientific meeting in San Antonio.

June 22, 2012

A drug maker has resubmitted its new drug application to the Food and Drug Administration for an acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

MOUNTAIN VIEW, Calif. — A drug maker has resubmitted its new drug application to the Food and Drug Administration for an acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

Alexza Pharmaceuticals said it received a complete response letter for Adasuve last month from the regulatory agency. The CRL outlined the FDA's concerns about Alexza's manufacturing facility and the drug's draft product labeling. Alexza said it believes it has addressed these concerns in its resubmitted application.

February 23, 2012

Coupons.com on Thursday announced the appointment of Dawn Lepore, former chairman and CEO of Drugstore.com, to its board of directors.

MOUNTAIN VIEW, Calif. — Coupons.com on Thursday announced the appointment of Dawn Lepore, former chairman and CEO of Drugstore.com, to its board of directors.

“Dawn is a widely admired business leader and e-commerce trail blazer,” Coupons.com founder and CEO Steven Boal said. “Her leadership, expertise in building successful online businesses and experience as a board member of such companies as eBay, Walmart and The New York Times Co. will be a great asset to us as we continue to rapidly grow our business.”

February 23, 2012

A panel of experts at the Food and Drug Administration has recommended approval for an obesity drug that so far had not met much success at the agency.

MOUNTAIN VIEW, Calif. — A panel of experts at the Food and Drug Administration has recommended approval for an obesity drug that so far had not met much success at the agency.

Vivus announced Wednesday that the FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 20-2 in favor of approving Qnexa (phentermine and topiramate) for obesity in adults. The FDA is not bound by advisory committee votes when it decides whether or not to approve a drug, but usually follows them.

December 14, 2011

A Food and Drug Administration panel has voted to recommend approval for a psychiatric drug made by Alexza Pharmaceuticals.

MOUNTAIN VIEW, Calif. — A Food and Drug Administration panel has voted to recommend approval for a psychiatric drug made by Alexza Pharmaceuticals.

December 7, 2011

Obese diabetes patients could experience weight loss when taking Vivus' anti-obesity drug, according to an oral presentation at the International Diabetes Federation's World Diabetes Congress in Dubai.

MOUNTAIN VIEW, Calif. — Obese diabetes patients could experience weight loss when taking Vivus' anti-obesity drug, according to an oral presentation at the International Diabetes Federation's World Diabetes Congress in Dubai.

November 17, 2011

The increase in the number of people with rheumatoid arthritis, and the challenges posed to drug makers by generics, is encouraging the development of new drugs for the disease, according to a new report by Frost & Sullivan.

MOUNTAIN VIEW, Calif. — The increase in the number of people with rheumatoid arthritis, and the challenges posed to drug makers by generics, is encouraging the development of new drugs for the disease, according to a new report by Frost & Sullivan.

October 17, 2011

Vivus has reapplied to the Food and Drug Administration for approval of a drug to treat obesity, the company said Monday.

MOUNTAIN VIEW, Calif. — Vivus has reapplied to the Food and Drug Administration for approval of a drug to treat obesity, the company said Monday.

Vivus said it sent in its regulatory approval application for Qnexa (phentermine and topiramate), a drug designed to treat obese and overweight patients by inducing and maintaining weight loss.

The company originally sought approval for the drug in October 2010, though the FDA declined to approve it.

October 4, 2011

Growing numbers of Americans with asthma and chronic obstructive pulmonary disease are driving innovation among drug makers, according to a new report by Frost & Sullivan.

MOUNTAIN VIEW, Calif. — Growing numbers of Americans with asthma and chronic obstructive pulmonary disease are driving innovation among drug makers, according to a new report by Frost & Sullivan.